Module 5 Quiz

A  the exclusion of electrolytes in certain measurements when pH, PCO2, and PO2 are elevated in arterial blood.

B  the exclusion of certain solids by increased activity of electrolytes when determining concentration of those solids.

C  an overestimation of electrolyte concentration by direct ISE measurements only when serum is used.

D  an underestimation of electrolyte concentration by indirect ISE methods when hyperproteinemia or hyperlipemia is present.

A  shift to the left.

B  remain unchanged.

C  shift to the right.

A  the hemoglobin binding capacity of blood.

B  the amount of total CO2 bound to hemoglobin.

C  the PO2 of alveolar air.

A  Sodium

B  Bicarbonate

C  Chloride

A  moles of osmotic substances per kilogram

B  moles per liter

C  moles of osmotic substances per liter

D  equivalents per liter

A  P50 is defined as the PO2 at which the hemoglobin of the blood is half saturated with O2.

B  oxygen saturation.

C  P50.

D  oxygen dissociation.

E  the half-life of oxygen.

A  Lp(a) contains a carbohydrate-rich protein called apo(a) that is covalently bound to apo B-100 through a disulfide linkage.

B  Lp(a) does not contain any apo B-100.

C  Lp(a) interacts with ABCA1 in peripheral cells, such as the macrophages, to remove additional cholesterol.

D  Lp(a) contains more core lipids, triglyceride, and cholesteryl ester and a smaller percent of protein.

A  HMG CoA reductase

B  Lecithin cholesterol acyltransferase

C  Fatty acid hydrolase

D  Cholesterol oxidase

A  prostaglandins.

B  terpenes.

C  acylglycerols.

D  sphingolipids.

A  enzymatic measurement of HDL occurs after non-HDL lipoproteins are removed by ultracentrifugation.

B  precipitation of non-HDL lipoproteins must occur using polyanions.

C  measurement of the rate of oxygen consumption occurs before removal of non-HDL lipoproteins.

D  there is no physical separation of HDL from the non-HDL fractions and HDL is selectively measured.

A  Tangier disease

B  Genetic lack of LDL receptors on cell surfaces

C  Lipoprotein lipase deficiency

D  Insulin deficiency

A  Exogenous

B  Reverse-cholesterol transport

C  Intracellular-cholesterol transport

D  Endogenous

A  It is an enzyme found in skeletal muscle and cardiac muscle and is released upon tissue injury.

B  CRP levels rise because of its presence in cardiac muscle and release upon muscle cell death.

C  It is an acute phase reactant plasma protein that rises in response to inflammation, which has been demonstrated to be associated with risk of future CHD.

D  It is a myocardial protein that regulates muscle contraction through interaction with myosin and actin.

A  Polarographic method

B  Self-monitoring method

C  Glucose oxidase method

D  Hexokinase method

A  Glycosylated hemoglobin

B  6-Phosphogluconate and hydrogen ions

C  Nicotinamide adenine dinucleotide and NADH

D  Glucose-6-phosphate and adenosine diphosphate (ADP)

A  glycogen; the liver

B  cellulose; vegetable fibers

C  starch; skeletal muscle

D  glycoprotein; cell membranes

A  Glucagon inhibits glycogenesis.

B  Glucagon inhibits gluconeogenesis.

C  Glucagon stimulates insulin release.

D  Glucagon stimulates gluconeogenesis.

A  glycolysis.

B  glycogenesis.

C  glyconeogenesis.

D  glycogenolysis.

A  glycogenesis.

B  glycogenolysis.

C  glycolysis.

D  gluconeogenesis.

A  Assessment of fasting blood glucose during a hypoglycemic episode

B  A 72-hour fast

C  Oral glucose tolerance test

D  Postprandial glucose analysis